Venofer and Venous thrombosis - a phase IV clinical study of FDA data

Summary:

Venous thrombosis is reported as a side effect among people who take Venofer (iron sucrose), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Telmisartan, and have Iron deficiency anaemia.

The phase IV clinical study analyzes which people have Venous thrombosis when taking Venofer. It is created by eHealthMe based on reports of 8,801 people who have side effects when taking Venofer from the FDA, and is updated regularly.

What is Venofer?

Venofer has active ingredients of iron sucrose. It is often used in anemia. eHealthMe is studying from 8,895 Venofer users. Check the latest studies of Venofer.

What is Venous thrombosis?

Venous thrombosis (blood clot (thrombus) that forms within a vein) is found to be associated with 554 drugs and 677 conditions by eHealthMe. Check the latest studies of Venous thrombosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

8,801 people reported to have side effects when taking Venofer.
Among them, 23 people (0.26%) have Venous thrombosis.

Among these 23 people:

How long have people been on Venofer when they have Venous thrombosis? *

What is the gender of people who have Venous thrombosis when taking Venofer? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Venous thrombosis when taking Venofer? *

What are other drugs people take besides Venofer? *

What are other side effects people have besides Venous thrombosis? *

Pain: 3 people, 13.04%
Injection Site Pain: 3 people, 13.04%
Oedema (fluid collection in tissue): 3 people, 13.04%
Injection Site Erythema (redness at injection site): 3 people, 13.04%
Rashes (redness): 3 people, 13.04%
Injection Site Warmth: 2 people, 8.70%
Injection Site Swelling: 2 people, 8.70%
Extravasation (leakage of a fluid): 2 people, 8.70%
Injection Site Irritation: 2 people, 8.70%
Hot Flush (sudden feelings of heat): 2 people, 8.70%

What are the existing conditions these people have? *

Iron Deficiency Anaemia: 6 people, 26.09%
Anaemia (lack of blood): 3 people, 13.04%
Rickets (softening of bones): 1 person, 4.35%
Insomnia (sleeplessness): 1 person, 4.35%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 1 person, 4.35%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 1 person, 4.35%
Hyperkalemia (damage to or disease of the kidney): 1 person, 4.35%
High Blood Pressure: 1 person, 4.35%
High Blood Cholesterol: 1 person, 4.35%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Venofer and have Venous thrombosis?

- Check whether Venous thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Venofer:

Venofer (8,895 reports)

Browse all side effects of Venofer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Venous thrombosis:

Venous thrombosis (554 drugs)

Browse all the conditions that are associated with Venous thrombosis:

Venous thrombosis (677 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on iron sucrose (the active ingredients of Venofer) and Venofer (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

No recent updates.